首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Microfluidic-based NanoLC/QQQ for high-sensitivity quantification of pharmaceutical molecules in small volumes of whole blood
【24h】

Microfluidic-based NanoLC/QQQ for high-sensitivity quantification of pharmaceutical molecules in small volumes of whole blood

机译:基于微流体的纳米/ QQQ,用于大量全血的药物分子的高灵敏度定量

获取原文

摘要

The creation of new pharmaceutical drugs consumes vast amounts of capital. The competition is intense and cost savings become essential, even for leading pharma-companies. Substantial savings can be achieved by miniaturization of laboratory processes. A prime example of this situation exists in the DMPK-laboratory. Cost per PK-study may be decreased markedly by reduction in rodent size and number, which is accompanied by a cutback in the amount of active pharmaceutical ingredient per PK-study. Yet, small animals can only donate limited sample volumes especially when serial sampling studies are performed to increase PK-data quality. Here we present the high-sensitivity quantification of pharmaceuticals from 10 (mu)L of whole blood utilizing a microfluidic-based nanoflow LC system coupled to a triple quadrupole mass spectrometer.
机译:新的药物毒品的创造消耗了大量资金。竞争激烈,节省成本变得至关重要,即使是领先的制药公司。通过实验室过程的小型化可以实现大量节省。 DMPK实验室存在这种情况的主要示例。通过降低啮齿动物的尺寸和数量可以显着降低每PK-研究的成本,其伴随着每PK-研究的活性药物成分的削减。然而,小动物只能捐赠有限的样本量,特别是当进行串行采样研究以增加PK数据质量时。在这里,我们利用耦合到三重四极孔质谱仪的微流体基纳米射线LC系统的10(MU)L1全血的高敏感性定量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号